Keyphrases
Overexpression
100%
C-Myc
100%
Oncogene
100%
Cytosine Arabinoside
100%
Prolymphocytic Leukemia
100%
Leukemic Cells
50%
High Dose
25%
Altered Expression
25%
Expression Level
25%
Cell Proliferation
25%
Peripheral Blood Lymphocytes
25%
B Lymphocytes
25%
Gene Sequencing
25%
Molecular Markers
25%
Chronic Lymphocytic Leukemia
25%
Histocompatibility Antigens
25%
Regulated Genes
25%
Sequence Encoding
25%
Invariant Chain
25%
G0 Phase
25%
Proliferating Activity
25%
Medicine and Dentistry
Oncogene C Myc
100%
Proto Oncogene
100%
Cytarabine
100%
Prolymphocytic Leukemia
100%
Disease
25%
Drug Megadose
25%
Lymphocyte
25%
Cell Proliferation
25%
B Lymphocyte
25%
Molecular Marker
25%
Cell Cycle
25%
Gene Sequence
25%
B-Cell Chronic Lymphocytic Leukemia
25%
Histocompatibility Antigen
25%
G0 Phase
25%
Biochemistry, Genetics and Molecular Biology
Cytosine
100%
Oncogene C Myc
100%
Proto Oncogene
100%
Drug Megadose
25%
B Cell
25%
Cell Proliferation
25%
Genetic Marker
25%
Cell Cycle
25%
Gene Sequence
25%
Peripheral Blood Lymphocyte
25%
G0 Phase
25%
Histocompatibility
25%
Invariant Chain
25%
Neuroscience
Oncogene C Myc
100%
Proto Oncogene
100%
Cytarabine
100%
Cell Cycle
25%
Lymphocyte
25%
Cell Proliferation
25%
B Cell
25%
Gene Sequence
25%
Cell Cycle G0 Phase
25%
Histocompatibility Antigen
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prolymphocytic Leukemia
100%